[B01AD01, streptokinase, The risk or severity of hypotension can be increased when Vardenafil is combined with Streptokinase.]
[J01EC01, sulfamethoxazole, The metabolism of Vardenafil can be decreased when combined with Sulfamethoxazole.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sulfisoxazole.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sulpiride.]
[L02BA01, tamoxifen, The metabolism of Vardenafil can be decreased when combined with Tamoxifen.]
[L01CB02, teniposide, The metabolism of Vardenafil can be decreased when combined with Teniposide.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Terbutaline.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Vardenafil.]
[G03BA03, testosterone, The metabolism of Vardenafil can be decreased when combined with Testosterone.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Tetrabenazine.]
[S03AA02, tetracycline, The metabolism of Vardenafil can be decreased when combined with Tetracycline.]
[N05AE05, lurasidone, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Lurasidone.]
[N04BC07, apomorphine, The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Vardenafil.]
[L04AX02, thalidomide, The metabolism of Vardenafil can be increased when combined with Thalidomide.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Eribulin.]
[N05CA19, thiopental, The metabolism of Vardenafil can be decreased when combined with Thiopental.]
[N05AB08, thioproperazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Thiothixene.]
[S01ED01, timolol, The risk or severity of QTc prolongation can be increased when Timolol is combined with Vardenafil.]
[M02AX02, tolazoline, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Tolazoline.]
[N06AF04, tranylcypromine, The metabolism of Vardenafil can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Vardenafil.]
[L01XF01, tretinoin, The metabolism of Vardenafil can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Vardenafil can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The risk or severity of hypotension can be increased when Vardenafil is combined with Triamterene.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Vardenafil.]
[C03AA06, trichlormethiazide, Vardenafil may increase the antihypertensive activities of Trichlormethiazide.]
[N05AB06, trifluoperazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Trifluoperazine.]
[R03BA07, mometasone, The metabolism of Vardenafil can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Trimebutine.]
[S01ED04, metipranolol, The risk or severity of hypotension can be increased when Vardenafil is combined with Metipranolol.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Vardenafil.]
[C02BA01, trimethaphan, Vardenafil may increase the antihypertensive activities of Trimethaphan.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Vardenafil.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Vardenafil.]
[J01FA08, troleandomycin, The metabolism of Vardenafil can be decreased when combined with Troleandomycin.]
[C09CA09, azilsartan medoxomil, Vardenafil may increase the antihypertensive activities of Azilsartan medoxomil.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vandetanib.]
[L02BX03, abiraterone, The metabolism of Vardenafil can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Vardenafil can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Vardenafil can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Vardenafil can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Vardenafil can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ezogabine.]
[B01AF01, rivaroxaban, The serum concentration of Rivaroxaban can be increased when it is combined with Vardenafil.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be increased when it is combined with Vardenafil.]
[B01AC24, ticagrelor, The metabolism of Vardenafil can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Vardenafil can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Vardenafil can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vardenafil can be decreased when combined with Vinblastine.]
[C04AX07, vincamine, Vardenafil may increase the antihypertensive activities of Vincamine.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Vardenafil.]
[C03BA10, xipamide, Vardenafil may increase the antihypertensive activities of Xipamide.]
[N05AF05, zuclopenthixol, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Zuclopenthixol.]
[J05AE02, indinavir, The serum concentration of Vardenafil can be increased when it is combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Vardenafil can be increased when it is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The metabolism of Vardenafil can be decreased when combined with Brentuximab vedotin.]
[L01ED01, crizotinib, The metabolism of Vardenafil can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Vardenafil can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Vardenafil can be decreased when combined with Rabeprazole.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Vardenafil.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ziprasidone.]
[G04BD07, tolterodine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Tolterodine.]
[C07AB03, atenolol, Vardenafil may increase the antihypertensive activities of Atenolol.]
[J02AC03, voriconazole, The metabolism of Vardenafil can be decreased when combined with Voriconazole.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Atropine.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Vardenafil.]
[R07AX02, ivacaftor, The metabolism of Vardenafil can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Vardenafil can be increased when combined with Prednylidene.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Vardenafil.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Vardenafil.]
[G04BD12, mirabegron, The serum concentration of Mirabegron can be increased when it is combined with Vardenafil.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be increased when it is combined with Vardenafil.]
[V03AX03, cobicistat, The metabolism of Vardenafil can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Vardenafil can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Vardenafil can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Vardenafil.]
[L01EX05, regorafenib, The metabolism of Vardenafil can be decreased when combined with Regorafenib.]
[J05AE04, nelfinavir, The metabolism of Vardenafil can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Vardenafil.]
[S01GA07, brimonidine, The risk or severity of hypotension can be increased when Vardenafil is combined with Brimonidine.]
[N04BD02, rasagiline, The risk or severity of hypotension can be increased when Vardenafil is combined with Rasagiline.]
[C08CA13, lercanidipine, Vardenafil may increase the antihypertensive activities of Lercanidipine.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Vardenafil.]
[H01CB05, pasireotide, The metabolism of Vardenafil can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The risk or severity of adverse effects can be increased when Sildenafil is combined with Vardenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Vardenafil.]
[B01AF02, apixaban, The serum concentration of Apixaban can be increased when it is combined with Vardenafil.]
[C10AX12, lomitapide, The metabolism of Vardenafil can be decreased when combined with Lomitapide.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Bedaquiline.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Bencyclane.]
[C03AA01, bendroflumethiazide, Vardenafil may increase the antihypertensive activities of Bendroflumethiazide.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Vardenafil.]
[A10BK02, canagliflozin, The serum concentration of Canagliflozin can be increased when it is combined with Vardenafil.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Moxifloxacin.]
[A06AX06, tegaserod, The serum concentration of Tegaserod can be increased when it is combined with Vardenafil.]
[L04AA18, everolimus, The metabolism of Vardenafil can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vardenafil.]
[L01EC02, dabrafenib, The metabolism of Vardenafil can be decreased when combined with Dabrafenib.]
[L01EB03, afatinib, The serum concentration of Afatinib can be increased when it is combined with Vardenafil.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be increased when it is combined with Vardenafil.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Bepridil.]
[C02KX05, riociguat, Vardenafil may increase the hypotensive activities of Riociguat.]
[C02KX04, macitentan, Vardenafil may increase the antihypertensive activities of Macitentan.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Vardenafil.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Vardenafil.]
[J05AP05, simeprevir, The metabolism of Vardenafil can be decreased when combined with Simeprevir.]
[S01EA03, apraclonidine, The risk or severity of hypotension can be increased when Vardenafil is combined with Apraclonidine.]
[J05AP08, sofosbuvir, The serum concentration of Sofosbuvir can be increased when it is combined with Vardenafil.]
[A10BK01, dapagliflozin, The risk or severity of hypotension can be increased when Vardenafil is combined with Dapagliflozin.]
[C07AB04, acebutolol, Vardenafil may increase the antihypertensive activities of Acebutolol.]
[A16AA07, metreleptin, The metabolism of Vardenafil can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Vardenafil can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Vardenafil can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, Vardenafil may increase the antihypertensive activities of Betaxolol.]
[C02CC01, bethanidine, Vardenafil may increase the antihypertensive activities of Bethanidine.]
[L04AC11, siltuximab, The metabolism of Vardenafil can be decreased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Vardenafil can be decreased when combined with Ceritinib.]
[B01AC26, vorapaxar, The serum concentration of Vardenafil can be increased when it is combined with Vorapaxar.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vardenafil.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Vardenafil.]
[L01EM01, idelalisib, The metabolism of Vardenafil can be decreased when combined with Idelalisib.]
[A10BK03, empagliflozin, The risk or severity of hypotension can be increased when Vardenafil is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Olodaterol.]
[N05CM19, suvorexant, The serum concentration of Vardenafil can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The serum concentration of Vardenafil can be increased when it is combined with Eliglustat.]
[N05AA04, acepromazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Acepromazine.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Vardenafil.]
[L01EX09, nintedanib, The serum concentration of Nintedanib can be increased when it is combined with Vardenafil.]
[J05AP09, dasabuvir, The serum concentration of Dasabuvir can be increased when it is combined with Vardenafil.]
[L01XK01, olaparib, The metabolism of Vardenafil can be decreased when combined with Olaparib.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Vardenafil.]
[N06AX11, mirtazapine, The metabolism of Vardenafil can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Vardenafil can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Vardenafil can be decreased when combined with Palbociclib.]
[L01EX08, lenvatinib, The serum concentration of Lenvatinib can be increased when it is combined with Vardenafil.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Vardenafil.]
[J05AP07, daclatasvir, The serum concentration of Vardenafil can be increased when it is combined with Daclatasvir.]
[N02BE01, acetaminophen, The metabolism of Vardenafil can be decreased when combined with Acetaminophen.]
[C01EB17, ivabradine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ivabradine.]
[J05AP06, asunaprevir, The serum concentration of Vardenafil can be increased when it is combined with Asunaprevir.]
[N05AX16, brexpiprazole, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Brexpiprazole.]
[A04AD14, rolapitant, The serum concentration of Vardenafil can be increased when it is combined with Rolapitant.]
[G02CX02, flibanserin, The serum concentration of Vardenafil can be increased when it is combined with Flibanserin.]
[S01EC01, acetazolamide, The metabolism of Vardenafil can be decreased when combined with Acetazolamide.]
[A02BC03, lansoprazole, The metabolism of Vardenafil can be decreased when combined with Lansoprazole.]
[J02AC05, isavuconazole, The metabolism of Vardenafil can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be increased when it is combined with Vardenafil.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Vardenafil.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Vardenafil.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Vardenafil.]
[G04CA01, alfuzosin, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Alfuzosin.]
[J05AP10, elbasvir, The metabolism of Vardenafil can be decreased when combined with Elbasvir.]
[J05AP11, grazoprevir, The serum concentration of Grazoprevir can be increased when it is combined with Vardenafil.]
[L01XX52, venetoclax, The metabolism of Vardenafil can be decreased when combined with Venetoclax.]
[N04BC01, bromocriptine, The metabolism of Vardenafil can be decreased when combined with Bromocriptine.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Vardenafil.]
[C08CA01, amlodipine, Vardenafil may increase the antihypertensive activities of Amlodipine.]
[C03CA02, bumetanide, The risk or severity of hypotension can be increased when Vardenafil is combined with Bumetanide.]
[S01ED03, levobunolol, The risk or severity of hypotension can be increased when Vardenafil is combined with Levobunolol.]
[N01BB01, bupivacaine, The risk or severity of hypotension can be increased when Vardenafil is combined with Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Vardenafil can be decreased when combined with Buprenorphine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Buserelin.]
[N05BE01, buspirone, The metabolism of Vardenafil can be decreased when combined with Buspirone.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Arsenic trioxide.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Artemether.]
[M02AA03, clofezone, The metabolism of Vardenafil can be decreased when combined with Rabeprazole.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Vardenafil.]
[S01GX07, azelastine, The metabolism of Vardenafil can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Vardenafil can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Vardenafil can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Vardenafil.]
[C09AA07, benazepril, Vardenafil may increase the antihypertensive activities of Benazepril.]
[J05AE09, tipranavir, The metabolism of Vardenafil can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Vardenafil.]
[L04AB02, infliximab, The metabolism of Vardenafil can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Vardenafil can be decreased when combined with Midostaurin.]
[L04AC14, sarilumab, The metabolism of Vardenafil can be decreased when combined with Sarilumab.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Delafloxacin.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Vardenafil.]
[D01AC10, bifonazole, The metabolism of Vardenafil can be decreased when combined with Bifonazole.]
[L01XX59, enasidenib, The metabolism of Vardenafil can be decreased when combined with Enasidenib.]
[L01EH02, neratinib, The serum concentration of Vardenafil can be increased when it is combined with Neratinib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vardenafil.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vorinostat.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Vardenafil.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Vardenafil.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Vardenafil.]
[J05AG03, efavirenz, The metabolism of Vardenafil can be decreased when combined with Efavirenz.]
[C01DX19, nesiritide, The risk or severity of hypotension can be increased when Vardenafil is combined with Nesiritide.]
[R03BA02, budesonide, The metabolism of Vardenafil can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Vardenafil can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Vardenafil can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Butriptyline.]
[C01AA02, acetyldigoxins, Vardenafil may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.]
[N01BX04, capsaicin, The metabolism of Vardenafil can be decreased when combined with Capsaicin.]
[A10BK04, ertugliflozin, The serum concentration of Ertugliflozin can be increased when it is combined with Vardenafil.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Acrivastine.]
[C09AA01, captopril, Vardenafil may increase the antihypertensive activities of Captopril.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Macimorelin.]
[L02BB05, apalutamide, The serum concentration of Vardenafil can be decreased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Vardenafil.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Carbinoxamine.]
[C07AG02, carvedilol, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Carvedilol.]
[B02BX09, fostamatinib, The metabolism of Vardenafil can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Vardenafil can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The serum concentration of Avatrombopag can be increased when it is combined with Vardenafil.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Encorafenib.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Vardenafil.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Celiprolol.]
[H01CC03, elagolix, The serum concentration of Elagolix can be increased when it is combined with Vardenafil.]
[L01XX62, ivosidenib, The metabolism of Vardenafil can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Vardenafil can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, The serum concentration of Lusutrombopag can be increased when it is combined with Vardenafil.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Vardenafil.]
[L01EM04, duvelisib, The serum concentration of Duvelisib can be increased when it is combined with Vardenafil.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be increased when it is combined with Vardenafil.]
[J01AA14, sarecycline, The serum concentration of Vardenafil can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Vardenafil.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Vardenafil.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Inotersen.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Vardenafil.]
[R03BB08, revefenacin, The serum concentration of Revefenacin can be increased when it is combined with Vardenafil.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Vardenafil.]
[L04AA39, emapalumab, The metabolism of Vardenafil can be increased when combined with Emapalumab.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Vardenafil.]
[L01EX13, gilteritinib, The serum concentration of Gilteritinib can be increased when it is combined with Vardenafil.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Amifampridine.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Vardenafil.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cibenzoline.]
[C09AA08, cilazapril, Vardenafil may increase the antihypertensive activities of Cilazapril.]
[B01AC23, cilostazol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cilostazol.]
[S01ED05, carteolol, The risk or severity of hypotension can be increased when Vardenafil is combined with Carteolol.]
[P02BX04, triclabendazole, The metabolism of Vardenafil can be decreased when combined with Triclabendazole.]
[J01FA09, clarithromycin, The serum concentration of Vardenafil can be increased when it is combined with Clarithromycin.]
[L01EN01, erdafitinib, The serum concentration of Vardenafil can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The serum concentration of Clobazam can be increased when it is combined with Vardenafil.]
[H02AB14, cloprednol, The metabolism of Vardenafil can be increased when combined with Cloprednol.]
[C09CA06, candesartan, Vardenafil may increase the antihypertensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Vardenafil can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Vardenafil can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Vardenafil can be decreased when combined with Alpelisib.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be increased when it is combined with Vardenafil.]
[C03BX03, cicletanine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cicletanine.]
[L01EJ02, fedratinib, The serum concentration of Fedratinib can be increased when it is combined with Vardenafil.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Vardenafil can be decreased when it is combined with Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Vardenafil.]
[N04CX01, istradefylline, The serum concentration of Vardenafil can be increased when it is combined with Istradefylline.]
[C03AA09, cyclothiazide, Vardenafil may increase the antihypertensive activities of Cyclothiazide.]
[J01XX09, daptomycin, The serum concentration of Daptomycin can be increased when it is combined with Vardenafil.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Vardenafil.]
[N02CC08, lasmiditan, The serum concentration of Vardenafil can be increased when it is combined with Lasmiditan.]
[N03AX25, cenobamate, The metabolism of Vardenafil can be decreased when combined with Cenobamate.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Vardenafil.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Vardenafil.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Vardenafil.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Dexchlorpheniramine.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Vardenafil.]
[L01XX72, tazemetostat, The serum concentration of Tazemetostat can be increased when it is combined with Vardenafil.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Vardenafil.]
[J05AB16, remdesivir, The metabolism of Vardenafil can be decreased when combined with Remdesivir.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Vardenafil can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Vardenafil can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Vardenafil.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Vardenafil.]
[C08CA16, clevidipine, The metabolism of Vardenafil can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Vardenafil can be decreased when combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Vardenafil can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Vardenafil can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Chlorcyclizine.]
[C02AA06, methoserpidine, Vardenafil may increase the antihypertensive activities of Methoserpidine.]
[L01EH03, tucatinib, Tucatinib may decrease the excretion rate of Vardenafil which could result in a higher serum level.]
[L01EX17, capmatinib, The serum concentration of Vardenafil can be increased when it is combined with Capmatinib.]
[N04BX04, opicapone, The risk or severity of hypotension can be increased when Vardenafil is combined with Opicapone.]
[D07XB03, fluprednidene, The metabolism of Vardenafil can be increased when combined with Fluprednidene.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be increased when it is combined with Vardenafil.]
[C08CA17, levamlodipine, Vardenafil may increase the antihypertensive activities of Levamlodipine.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ebastine.]
[J05AX29, fostemsavir, The serum concentration of Fostemsavir can be increased when it is combined with Vardenafil.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Vardenafil.]
[L04AC19, satralizumab, The serum concentration of Vardenafil can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Vardenafil can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, Vardenafil may increase the antihypertensive activities of Chlorothiazide.]
[R06AB04, chlorpheniramine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Chlorpromazine.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Chlorprothixene.]
[C03BA04, chlorthalidone, Vardenafil may increase the antihypertensive activities of Chlorthalidone.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Vardenafil.]
[A16AX20, lonafarnib, The metabolism of Vardenafil can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Vardenafil.]
[L04AD03, voclosporin, The serum concentration of Voclosporin can be increased when it is combined with Vardenafil.]
[P03AX07, abametapir, The serum concentration of Vardenafil can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of hypotension can be increased when Vardenafil is combined with Vericiguat.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Vardenafil.]
[L01EX25, umbralisib, The serum concentration of Vardenafil can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, The serum concentration of Trilaciclib can be increased when it is combined with Vardenafil.]
[N03AX10, felbamate, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Felbamate.]
[C01CA19, fenoldopam, Vardenafil may increase the antihypertensive activities of Fenoldopam.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Vardenafil.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Flumequine.]
[R03CC15, formoterol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Formoterol.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Vardenafil.]
[L01EK03, tivozanib, The serum concentration of Tivozanib can be increased when it is combined with Vardenafil.]
[H04AA02, dasiglucagon, Vardenafil may increase the antihypertensive activities of Dasiglucagon.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Vardenafil.]
[A02BA01, cimetidine, The metabolism of Vardenafil can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cinnarizine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Vardenafil can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Vardenafil can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The metabolism of Vardenafil can be decreased when combined with Citalopram.]
[L04AA48, belumosudil, The serum concentration of Vardenafil can be increased when it is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Vardenafil can be decreased when combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mobocertinib.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Vardenafil.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Clemastine.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Vardenafil.]
[N06AX25, St. John's wort extract, The metabolism of Vardenafil can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Vardenafil can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, The serum concentration of Vardenafil can be increased when it is combined with Maribavir.]
[D11AH08, abrocitinib, The serum concentration of Vardenafil can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, The metabolism of Vardenafil can be decreased when combined with Clofazimine.]
[B06AX04, mitapivat, The serum concentration of Vardenafil can be increased when it is combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of hypotension can be increased when Vardenafil is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Vardenafil can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Vardenafil.]
[N06AA04, clomipramine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Clomipramine.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Vardenafil.]
[C01EB24, mavacamten, The serum concentration of Vardenafil can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Vardenafil.]
[A04AA01, ondansetron, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Granisetron.]
[L01XX77, adagrasib, The serum concentration of Vardenafil can be increased when it is combined with Adagrasib.]
[N05AH02, clozapine, The metabolism of Vardenafil can be decreased when combined with Clozapine.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Vardenafil.]
[A10BK06, sotagliflozin, The serum concentration of Vardenafil can be increased when it is combined with Sotagliflozin.]
[H01AC08, somatrogon, The metabolism of Vardenafil can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cocaine.]
[C02KB01, metyrosine, Vardenafil may increase the antihypertensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Vardenafil can be increased when combined with Bimekizumab.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Vardenafil.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Desflurane.]
[A10BX03, nateglinide, The metabolism of Vardenafil can be decreased when combined with Nateglinide.]
[J01FA15, telithromycin, The metabolism of Vardenafil can be decreased when combined with Telithromycin.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Desloratadine.]
[J02AC02, itraconazole, The serum concentration of Vardenafil can be increased when it is combined with Itraconazole.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Emedastine.]
[N05BA10, ketazolam, The metabolism of Vardenafil can be decreased when combined with Ketazolam.]
[L01EA01, imatinib, The metabolism of Vardenafil can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Vardenafil can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Lacidipine.]
[N03AX09, lamotrigine, The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Vardenafil.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Levocabastine.]
[S01BA03, cortisone, The metabolism of Vardenafil can be increased when combined with Cortisone.]
[N07BC04, lofexidine, Vardenafil may increase the antihypertensive activities of Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Lomefloxacin.]
[C09AA03, lisinopril, Vardenafil may increase the antihypertensive activities of Lisinopril.]
[C08CA11, manidipine, The metabolism of Vardenafil can be decreased when combined with Manidipine.]
[H02AB15, meprednisone, The metabolism of Vardenafil can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Vardenafil can be decreased when combined with Mequitazine.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Adenosine.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cyclizine.]
[C03DA04, eplerenone, Vardenafil may increase the antihypertensive activities of Eplerenone.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Melperone.]
[C03AA07, cyclopenthiazide, Vardenafil may increase the antihypertensive activities of Cyclopenthiazide.]
[J01FA03, midecamycin, The metabolism of Vardenafil can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Vardenafil.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Vardenafil.]
[S01XA18, cyclosporine, The metabolism of Vardenafil can be decreased when combined with Cyclosporine.]
[N06BA07, modafinil, The metabolism of Vardenafil can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Vardenafil.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Vardenafil.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Vardenafil.]
[C03XA02, conivaptan, The metabolism of Vardenafil can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, Vardenafil may increase the antihypertensive activities of Moxonidine.]
[S01AA13, fusidic acid, The metabolism of Vardenafil can be decreased when combined with Fusidic acid.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Pipemidic acid.]
[M01AH05, etoricoxib, The metabolism of Vardenafil can be decreased when combined with Etoricoxib.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Vardenafil.]
[G03XA01, danazol, The metabolism of Vardenafil can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Vardenafil can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Vardenafil can be decreased when combined with Daunorubicin.]
[C02CC04, debrisoquin, Vardenafil may increase the antihypertensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of hypotension can be increased when Vardenafil is combined with Nabilone.]
[C07AB12, nebivolol, Vardenafil may increase the antihypertensive activities of Nebivolol.]
[N06AX06, nefazodone, The metabolism of Vardenafil can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Vardenafil may increase the hypotensive activities of Nicorandil.]
[N06AB10, escitalopram, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Solifenacin.]
[N06AA01, desipramine, The metabolism of Vardenafil can be decreased when combined with Desipramine.]
[C09XA02, aliskiren, Vardenafil may increase the antihypertensive activities of Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Oxaliplatin.]
[N03AF02, oxcarbazepine, The metabolism of Vardenafil can be decreased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Vardenafil can be decreased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Vardenafil can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Vardenafil can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Vardenafil can be decreased when combined with Gefitinib.]
[R05DA09, dextromethorphan, The metabolism of Vardenafil can be decreased when combined with Dextromethorphan.]
[N06AB05, paroxetine, The metabolism of Vardenafil can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Vardenafil can be decreased when combined with Clopidogrel.]
[C01DA05, pentaerythritol tetranitrate, The risk or severity of hypotension can be increased when Vardenafil is combined with Pentaerythritol tetranitrate.]
[A03AX15, peppermint oil, The metabolism of Vardenafil can be decreased when combined with Peppermint oil.]
[N05BA01, diazepam, The metabolism of Vardenafil can be decreased when combined with Diazepam.]
[V03AH01, diazoxide, Vardenafil may increase the antihypertensive activities of Diazoxide.]
[S01EC02, dichlorphenamide, The risk or severity of hypotension can be increased when Vardenafil is combined with Diclofenamide.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Vardenafil.]
[C02DG01, pinacidil, Vardenafil may increase the antihypertensive activities of Pinacidil.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Pinaverium.]
[N05AD05, pipamperone, The risk or severity of hypotension can be increased when Vardenafil is combined with Pipamperone.]
[L01DC04, ixabepilone, The serum concentration of Vardenafil can be increased when it is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Vardenafil can be decreased when combined with Erlotinib.]
[L02AA01, diethylstilbestrol, The metabolism of Vardenafil can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Vardenafil can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Vardenafil can be increased when combined with Difluocortolone.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Vardenafil.]
[C01AA05, digoxin, Vardenafil may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Vardenafil may increase the antihypertensive activities of Dihydralazine.]
[N02CA01, dihydroergotamine, The metabolism of Vardenafil can be decreased when combined with Dihydroergotamine.]
[J05AE08, atazanavir, The serum concentration of Vardenafil can be increased when it is combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Vardenafil.]
[C08DB01, diltiazem, The metabolism of Vardenafil can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Dimenhydrinate.]
[M02AX03, dimethyl sulfoxide, The metabolism of Vardenafil can be decreased when combined with Dimethyl sulfoxide.]
[C05CA03, diosmin, The serum concentration of Vardenafil can be increased when it is combined with Diosmin.]
[R06AA02, diphenhydramine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Diphenhydramine.]
[C09AA06, quinapril, Vardenafil may increase the antihypertensive activities of Quinapril.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Vardenafil is combined with Dipyridamole.]
[A03FA02, cisapride, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cisapride.]
[C09AA05, ramipril, Vardenafil may increase the antihypertensive activities of Ramipril.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Vardenafil.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Disopyramide.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Vardenafil.]
[S02AA12, rifamycin SV, The metabolism of Vardenafil can be decreased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Vardenafil can be increased when combined with Rifapentine.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Vardenafil.]
[N05AX08, risperidone, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of hypotension can be increased when Vardenafil is combined with Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Vardenafil.]
[L01EX01, sunitinib, The metabolism of Vardenafil can be decreased when combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Vardenafil can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Vardenafil.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Vardenafil.]
[G04BE08, tadalafil, The risk or severity of adverse effects can be increased when Tadalafil is combined with Vardenafil.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Vardenafil.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Vardenafil.]
[R03AC12, salmeterol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Salmeterol.]
[A03FA03, domperidone, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Domperidone.]
[N06AA16, dothiepin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Dosulepin.]
[N06AA12, doxepin, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Doxepin.]
[L01DB01, doxorubicin, The metabolism of Vardenafil can be decreased when combined with Doxorubicin.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Vardenafil.]
[N01AB08, sevoflurane, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sevoflurane.]
[N05AD08, droperidol, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Droperidol.]
[C10AA01, simvastatin, The serum concentration of Vardenafil can be increased when it is combined with Simvastatin.]
[C09AA11, spirapril, Vardenafil may increase the antihypertensive activities of Spirapril.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sultopride.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Vardenafil.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Temafloxacin.]
[G04CA03, terazosin, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Terazosin.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Terodiline.]
[C09AA02, enalapril, Vardenafil may increase the antihypertensive activities of Enalapril.]
[G01AF08, tioconazole, The metabolism of Vardenafil can be decreased when combined with Tioconazole.]
[N05BA23, tofisopam, The metabolism of Vardenafil can be decreased when combined with Tofisopam.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Vardenafil.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Toremifene.]
[C03CA04, torsemide, Vardenafil may increase the antihypertensive activities of Torasemide.]
[C09AA10, trandolapril, Vardenafil may increase the antihypertensive activities of Trandolapril.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Triptorelin.]
[C02CA06, urapidil, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Urapidil.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Vardenafil.]
[S01GX10, epinastine, The risk or severity of QTc prolongation can be increased when Epinastine is combined with Vardenafil.]
[C08CA12, mepirodipine, The metabolism of Vardenafil can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Vardenafil can be decreased when combined with Epinephrine.]
[C09AA15, zofenopril, Vardenafil may increase the antihypertensive activities of Zofenopril.]
[N03AX15, zonisamide, The serum concentration of Vardenafil can be increased when it is combined with Zonisamide.]
[C02AC02, guanfacine, Vardenafil may increase the antihypertensive activities of Guanfacine.]
[B01AC11, iloprost, The risk or severity of hypotension can be increased when Vardenafil is combined with Iloprost.]
[C01BG01, moricizine, The risk or severity of QTc prolongation can be increased when Moricizine is combined with Vardenafil.]
[N02CA02, ergotamine, The metabolism of Vardenafil can be decreased when combined with Ergotamine.]
[C01DA13, erythrityl tetranitrate, The risk or severity of hypotension can be increased when Vardenafil is combined with Erythrityl tetranitrate.]
[S01AA17, erythromycin, The serum concentration of Vardenafil can be increased when it is combined with Erythromycin.]
[G03CA03, estradiol, The metabolism of Vardenafil can be decreased when combined with Estradiol.]
[R03BA09, fluticasone furoate, The metabolism of Vardenafil can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Vardenafil can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Vardenafil can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Vardenafil.]
[V03AF05, amifostine, The risk or severity of hypotension can be increased when Vardenafil is combined with Amifostine.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ibutilide.]
[N03AD01, ethosuximide, The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Vardenafil.]
[L01CB01, etoposide, The metabolism of Vardenafil can be decreased when combined with Etoposide.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ajmaline.]
[L04AD02, tacrolimus, The metabolism of Vardenafil can be decreased when combined with Tacrolimus.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Vardenafil can be decreased when combined with Astemizole.]
[R06AX12, terfenadine, The metabolism of Vardenafil can be decreased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Vardenafil can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Encainide.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Leuprolide.]
[C10AA03, pravastatin, The serum concentration of Pravastatin can be increased when it is combined with Vardenafil.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Famotidine.]
[C08CA02, felodipine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Fendiline.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Salbutamol.]
[L01BB06, clofarabine, The risk or severity of hypotension can be increased when Vardenafil is combined with Clofarabine.]
[C01BC04, flecainide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Flecainide.]
[J02AC01, fluconazole, The metabolism of Vardenafil can be decreased when combined with Fluconazole.]
[D07AC08, fluocinonide, The metabolism of Vardenafil can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Vardenafil can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Vardenafil can be decreased when combined with Ethanol.]
[L01BC02, fluorouracil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Fluorouracil.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Vardenafil.]
[N05AF01, flupenthixol, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Flupentixol.]
[N05AG01, fluspirilene, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Vardenafil can be decreased when combined with Flutamide.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Vardenafil.]
[J05AE10, darunavir, The serum concentration of Vardenafil can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, Vardenafil may increase the antihypertensive activities of Furosemide.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Amisulpride.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vardenafil.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Gallopamil.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Degarelix.]
[L01EA02, dasatinib, The metabolism of Vardenafil can be decreased when combined with Dasatinib.]
[N04BC06, cabergoline, The metabolism of Vardenafil can be decreased when combined with Cabergoline.]
[N03AD03, methsuximide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Methsuximide.]
[N01AH02, alfentanil, The metabolism of Vardenafil can be decreased when combined with Alfentanil.]
[L01EH01, lapatinib, The metabolism of Vardenafil can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Vardenafil can be decreased when combined with Glyburide.]
[N05CM18, dexmedetomidine, The risk or severity of hypotension can be increased when Vardenafil is combined with Dexmedetomidine.]
[C05AE01, nitroglycerin, The risk or severity of hypotension can be increased when Vardenafil is combined with Nitroglycerin.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Dofetilide.]
[C02CA04, doxazosin, The risk or severity of hypotension can be increased when Vardenafil is combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Vardenafil can be decreased when combined with Sorafenib.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Vardenafil.]
[C09AA09, fosinopril, Vardenafil may increase the antihypertensive activities of Fosinopril.]
[S01EX01, guanethidine, Vardenafil may increase the antihypertensive activities of Guanethidine.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Goserelin.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Halofantrine.]
[N05AD01, haloperidol, The metabolism of Vardenafil can be decreased when combined with Haloperidol.]
[N01AB01, halothane, The risk or severity of hypotension can be increased when Vardenafil is combined with Halothane.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Histrelin.]
[N05AH04, quetiapine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Quetiapine.]
[L01CE02, irinotecan, The metabolism of Vardenafil can be decreased when combined with Irinotecan.]
[C09CA01, losartan, The metabolism of Vardenafil can be decreased when combined with Losartan.]
[J05AG01, nevirapine, The metabolism of Vardenafil can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Vardenafil can be decreased when combined with Nilvadipine.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Oxatomide.]
[C09AA04, perindopril, Vardenafil may increase the antihypertensive activities of Perindopril.]
[C02DB02, hydralazine, The metabolism of Vardenafil can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Vardenafil can be decreased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, Vardenafil may increase the antihypertensive activities of Hydroflumethiazide.]
[G04BD06, propiverine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Hydroxychloroquine.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Hydroxyzine.]
[C02AC06, rilmenidine, Vardenafil may increase the antihypertensive activities of Rilmenidine.]
[L01AA06, ifosfamide, The metabolism of Vardenafil can be decreased when combined with Ifosfamide.]
[N01AH03, sufentanil, The risk or severity of hypotension can be increased when Vardenafil is combined with Sufentanil.]
[N06AA02, imipramine, The serum concentration of Imipramine can be increased when it is combined with Vardenafil.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Vardenafil.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Terlipressin.]
[M03BX02, tizanidine, The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Vardenafil.]
[L01CE01, topotecan, The metabolism of Vardenafil can be decreased when combined with Topotecan.]
[C03BA11, indapamide, The risk or severity of QTc prolongation can be increased when Indapamide is combined with Vardenafil.]
[C02CA02, indoramin, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Indoramin.]
[N06AX17, milnacipran, The metabolism of Vardenafil can be decreased when combined with Milnacipran.]
[A10BH01, sitagliptin, The serum concentration of Sitagliptin can be increased when it is combined with Vardenafil.]
[N05BA12, alprazolam, The metabolism of Vardenafil can be decreased when combined with Alprazolam.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vardenafil.]
[C10AA06, cerivastatin, The metabolism of Vardenafil can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Anagrelide.]
[C07AA01, alprenolol, Vardenafil may increase the antihypertensive activities of Alprenolol.]
[G04BE01, alprostadil, The risk or severity of hypotension and priapism can be increased when Vardenafil is combined with Alprostadil.]
[N06AF01, isocarboxazid, The risk or severity of hypotension can be increased when Vardenafil is combined with Isocarboxazid.]
[C09AA16, imidapril, Vardenafil may increase the antihypertensive activities of Imidapril.]
[N01AB06, isoflurane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Vardenafil.]
[J04AC01, isoniazid, The metabolism of Vardenafil can be decreased when combined with Isoniazid.]
[C05AE02, isosorbide dinitrate, The risk or severity of hypotension can be increased when Vardenafil is combined with Isosorbide dinitrate.]
[C04AA01, isoxsuprine, The risk or severity of hypotension can be increased when Vardenafil is combined with Isoxsuprine.]
[L04AC07, tocilizumab, The metabolism of Vardenafil can be increased when combined with Tocilizumab.]
[C02KD01, ketanserin, Vardenafil may increase the antihypertensive activities of Ketanserin.]
[J02AB02, ketoconazole, The serum concentration of Vardenafil can be increased when it is combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Olanzapine.]
[L04AA24, abatacept, The metabolism of Vardenafil can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mizolastine.]
[N04BC09, rotigotine, The risk or severity of hypotension can be increased when Vardenafil is combined with Rotigotine.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Nalidixic acid.]
[C07AG01, labetalol, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Amantadine.]
[C02AA05, deserpidine, Vardenafil may increase the antihypertensive activities of Deserpidine.]
[C03CC01, ethacrynic acid, The risk or severity of hypotension can be increased when Vardenafil is combined with Etacrynic acid.]
[G03AD01, levonorgestrel, The metabolism of Vardenafil can be decreased when combined with Levonorgestrel.]
[N04BA01, levodopa, The risk or severity of hypotension can be increased when Vardenafil is combined with Levodopa.]
[S02DA01, lidocaine, The metabolism of Vardenafil can be decreased when combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Lidoflazine.]
[N06BA13, armodafinil, The metabolism of Vardenafil can be increased when combined with Armodafinil.]
[C03DB01, amiloride, The risk or severity of hypotension can be increased when Vardenafil is combined with Amiloride.]
[A07DA03, loperamide, The excretion of Loperamide can be decreased when combined with Vardenafil.]
[C10AA02, lovastatin, The metabolism of Vardenafil can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The serum concentration of Vardenafil can be increased when it is combined with Loxapine.]
[L01EG01, temsirolimus, The serum concentration of Temsirolimus can be increased when it is combined with Vardenafil.]
[L01EA03, nilotinib, The metabolism of Vardenafil can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Vardenafil.]
[N06AA21, maprotiline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Maprotiline.]
[C02BB01, mecamylamine, Vardenafil may increase the antihypertensive activities of Mecamylamine.]
[C01AA08, medigoxin, Vardenafil may decrease the excretion rate of Metildigoxin which could result in a higher serum level.]
[P01BC02, mefloquine, The metabolism of Vardenafil can be decreased when combined with Mefloquine.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Dolasetron.]
[H01CB03, lanreotide, The metabolism of Vardenafil can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Vardenafil can be decreased when combined with Methadone.]
[S01EC05, methazolamide, The risk or severity of hypotension can be increased when Vardenafil is combined with Methazolamide.]
[H03BB02, methimazole, The metabolism of Vardenafil can be decreased when combined with Methimazole.]
[N05AA02, methotrimeprazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Methotrimeprazine.]
[C03AA08, methyclothiazide, The risk or severity of hypotension can be increased when Vardenafil is combined with Methyclothiazide.]
[C02AB01, methyldopa, Vardenafil may increase the antihypertensive activities of Methyldopa.]
[V04CG05, methylene blue, The metabolism of Vardenafil can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Vardenafil can be decreased when combined with Methylergometrine.]
[A03FA01, metoclopramide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Metoclopramide.]
[C03BA08, metolazone, Vardenafil may increase the antihypertensive activities of Metolazone.]
[C07AB02, metoprolol, Vardenafil may increase the antihypertensive activities of Metoprolol.]
[P01AB01, metronidazole, The metabolism of Vardenafil can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Vardenafil can be decreased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Vardenafil can be decreased when combined with Miconazole.]
[N05CD08, midazolam, The metabolism of Vardenafil can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Vardenafil can be decreased when combined with Mifepristone.]
[C09CA03, valsartan, Vardenafil may increase the antihypertensive activities of Valsartan.]
[D11AX01, minoxidil, Vardenafil may increase the antihypertensive activities of Minoxidil.]
[L01XX23, mitotane, The metabolism of Vardenafil can be increased when combined with Mitotane.]
[L03AC01, aldesleukin, The metabolism of Vardenafil can be decreased when combined with Aldesleukin.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Vardenafil.]
[C01BD01, amiodarone, The metabolism of Vardenafil can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Amitriptyline.]
[N02AA01, morphine, The serum concentration of Morphine can be increased when it is combined with Vardenafil.]
[L04AB05, certolizumab pegol, The metabolism of Vardenafil can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Vardenafil.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Vardenafil.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Vardenafil.]
[G03XC01, raloxifene, The metabolism of Vardenafil can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Amoxapine.]
[N03AB05, fosphenytoin, The metabolism of Vardenafil can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Vardenafil may increase the antihypertensive activities of Nadolol.]
[N04BC04, ropinirole, The risk or severity of hypotension can be increased when Vardenafil is combined with Ropinirole.]
[V03AB15, naloxone, The metabolism of Vardenafil can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Vardenafil can be increased when combined with Anakinra.]
[A10BG01, troglitazone, The metabolism of Vardenafil can be decreased when combined with Troglitazone.]
[N04BX01, tolcapone, The risk or severity of hypotension can be increased when Vardenafil is combined with Tolcapone.]
[L01CD02, docetaxel, The metabolism of Vardenafil can be decreased when combined with Docetaxel.]
[N01AH06, remifentanil, The risk or severity of hypotension can be increased when Vardenafil is combined with Remifentanil.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Levosimendan.]
[N05AX14, iloperidone, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of hypotension can be increased when Vardenafil is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Vardenafil can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Vardenafil may increase the antihypertensive activities of Telmisartan.]
[C08CA04, nicardipine, The metabolism of Vardenafil can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Nicergoline.]
[C08CA05, nifedipine, The risk or severity of hypotension can be increased when Vardenafil is combined with Nifedipine.]
[V03AB22, amyl nitrite, The risk or severity of hypotension can be increased when Vardenafil is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Vardenafil may increase the antihypertensive activities of Nimodipine.]
[C08CA07, nisoldipine, Vardenafil may increase the antihypertensive activities of Nisoldipine.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Nitrendipine.]
[R07AX01, nitric oxide, The metabolism of Vardenafil can be decreased when combined with Nitric Oxide.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Vardenafil.]
[N04BC05, pramipexole, The risk or severity of hypotension can be increased when Vardenafil is combined with Pramipexole.]
[C02DD01, nitroprusside, Vardenafil may increase the antihypertensive activities of Nitroprusside.]
[G03DC02, norethindrone, The metabolism of Vardenafil can be decreased when combined with Norethisterone.]
[S01AE02, norfloxacin, The metabolism of Vardenafil can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, Vardenafil may increase the antihypertensive activities of Bosentan.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Vardenafil.]
[R05DA07, noscapine, The metabolism of Vardenafil can be decreased when combined with Noscapine.]
[A16AX07, sapropterin, Sapropterin may increase the hypotensive activities of Vardenafil.]
[H01CB02, octreotide, The metabolism of Vardenafil can be decreased when combined with Octreotide.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ofloxacin.]
[J01FA05, oleandomycin, The metabolism of Vardenafil can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Vardenafil can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Vardenafil can be decreased when combined with Omeprazole.]
[G04CA02, tamsulosin, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Tamsulosin.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Oxolinic acid.]
[C07AA02, oxprenolol, Vardenafil may increase the antihypertensive activities of Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Vardenafil can be decreased when combined with Oxycodone.]
[A14AA05, oxymetholone, The metabolism of Vardenafil can be decreased when combined with Oxymetholone.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vardenafil.]
[N05AH05, asenapine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Asenapine.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Papaverine.]
[H02AB05, paramethasone, The metabolism of Vardenafil can be decreased when combined with Paramethasone.]
[C02KC01, pargyline, Vardenafil may increase the antihypertensive activities of Pargyline.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Vardenafil.]
[C07AA23, penbutolol, Vardenafil may increase the antihypertensive activities of Penbutolol.]
[N05AG03, penfluridol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Penfluridol.]
[N05CA01, pentobarbital, The metabolism of Vardenafil can be increased when combined with Pentobarbital.]
[C08EX02, perhexiline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Perhexiline.]
[N06AF03, phenelzine, The metabolism of Vardenafil can be decreased when combined with Phenelzine.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Pheniramine.]
[N03AA02, phenobarbital, The metabolism of Vardenafil can be increased when combined with Phenobarbital.]
[C04AX02, phenoxybenzamine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Phenoxybenzamine.]
[V03AB36, phentolamine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Phentolamine.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be decreased when Vardenafil is combined with Phenylephrine.]
[N03AB02, phenytoin, The metabolism of Vardenafil can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Vardenafil can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Levofloxacin.]
[L02BB03, bicalutamide, The metabolism of Vardenafil can be decreased when combined with Bicalutamide.]
[C08CX01, mibefradil, The metabolism of Vardenafil can be decreased when combined with Mibefradil.]
[S01EB01, pilocarpine, The metabolism of Vardenafil can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Vardenafil can be decreased when combined with Pimozide.]
[C07AA03, pindolol, Vardenafil may increase the antihypertensive activities of Pindolol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Vardenafil.]
[J05AE01, saquinavir, The serum concentration of Vardenafil can be increased when it is combined with Saquinavir.]
[C09CA02, eprosartan, Vardenafil may increase the antihypertensive activities of Eprosartan.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Grepafloxacin.]
[N02CX01, pizotyline, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Pizotifen.]
[J05AG02, delavirdine, The metabolism of Vardenafil can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Vardenafil can be decreased when combined with Irbesartan.]
[L04AC08, canakinumab, The metabolism of Vardenafil can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Vardenafil may increase the antihypertensive activities of Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Vardenafil can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Vardenafil.]
[C07AB01, practolol, Vardenafil may increase the antihypertensive activities of Practolol.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Prajmaline.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Vardenafil.]
[C02CA01, prazosin, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Prazosin.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Antazoline.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Prenylamine.]
[P01BA03, primaquine, The metabolism of Vardenafil can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Vardenafil can be increased when combined with Primidone.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Probucol.]
[C01BA02, procainamide, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Procainamide.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Prochlorperazine.]
[G03DA04, progesterone, The metabolism of Vardenafil can be decreased when combined with Progesterone.]
[N05AA03, promazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Promazine.]
[R06AD02, promethazine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Promethazine.]
[C01BC03, propafenone, The serum concentration of Vardenafil can be increased when it is combined with Propafenone.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Vardenafil.]
[N05AC01, periciazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Periciazine.]
[N05CM06, propiomazine, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Propiomazine.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Vardenafil.]
[N01AX10, propofol, The metabolism of Vardenafil can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Vardenafil can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, Vardenafil may increase the antihypertensive activities of Propranolol.]
[B01AC09, epoprostenol, Vardenafil may increase the antihypertensive activities of Epoprostenol.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Vardenafil.]
[N05AX12, aripiprazole, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Aripiprazole.]
[R06AC01, pyrilamine, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mepyramine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Vardenafil.]
[C01BA01, quinidine, The metabolism of Vardenafil can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Vardenafil can be decreased when combined with Quinine.]
[C02AA01, rescinnamine, Vardenafil may increase the antihypertensive activities of Rescinnamine.]
[C02AA02, reserpine, The serum concentration of Vardenafil can be increased when it is combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Vardenafil can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Vardenafil can be decreased when combined with Roxithromycin.]
[C05CA01, rutin, The metabolism of Vardenafil can be decreased when combined with Rutin.]
[N04BD01, selegiline, The risk or severity of hypotension can be increased when Vardenafil is combined with Selegiline.]
[L01FA03, obinutuzumab, The risk or severity of hypotension can be increased when Vardenafil is combined with Obinutuzumab.]
[H01CB01, somatostatin, The metabolism of Vardenafil can be decreased when combined with Somatostatin.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sotalol.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Vardenafil.]
[C03DA01, spironolactone, The risk or severity of hypotension can be increased when Vardenafil is combined with Spironolactone.]
[N03AG01, valproic acid, The metabolism of Vardenafil can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Vardenafil.]
[C01DA14, isosorbide mononitrate, Vardenafil may increase the vasodilatory activities of Isosorbide mononitrate.]
[H02CA04, levoketoconazole, The metabolism of Vardenafil can be decreased when combined with Levoketoconazole.]
